REGISTERED NUMBER: 06627770 (England and Wales)

Unaudited Financial Statements for the Year Ended 31 March 2025

for

Joint Injections Ltd

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTOR:

Mr M A Khan

SECRETARY:

Mrs N M Khan

REGISTERED OFFICE:

117 Granville Road

London

SW18 5SF

REGISTERED NUMBER:

06627770 (England and Wales)

ACCOUNTANTS:

Pertax Accountancy Ltd

Quatro House

Frimley Road

Camberley

GU16 7ER

FIXED ASSETS

Tangible assets

4

2,090

1,862

CURRENT ASSETS

Debtors

5

116,332

95,652

Cash at bank

17,698

6,692

134,030

102,344

CREDITORS

Amounts falling due within one year

6

(78,745

)

(35,675

)

NET CURRENT ASSETS

55,285

66,669

TOTAL ASSETS LESS CURRENT LIABILITIES

57,375

68,531

CREDITORS

Amounts falling due after more than one year

7

(1,604

)

(18,128

)

NET ASSETS

55,771

50,403

CAPITAL AND RESERVES

Called up share capital

2

2

Retained earnings

55,769

50,401

SHAREHOLDERS' FUNDS

55,771

50,403

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 31 December 2025 and were signed by:

Mr M A Khan - Director

1.	STATUTORY INFORMATION

Joint Injections Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

20% on reducing balance

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2024 - 2 ) .

4.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

At 1 April 2024

8,451

Additions

750

At 31 March 2025

9,201

DEPRECIATION

At 1 April 2024

6,589

Charge for year

522

At 31 March 2025

7,111

NET BOOK VALUE

At 31 March 2025

2,090

At 31 March 2024

1,862

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Other debtors

116,332

95,652

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Bank loans and overdrafts

8,091

-

Taxation and social security

29,333

34,225

Other creditors

41,321

1,450

78,745

35,675

7.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

2025

2024

£

£

Bank loans

1,604

18,128

8.	DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

Included within other debtors was an amount of £80,942 (2024 - £90,652), which was receivable from the director.